References
[1]Du ZD, Zhao D, Du J, Zhang YL, Lin Y, Liu C, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004[J]. Pediatr Infect Dis J, 2007, 26(5): 449-451.
[2]段超,杜忠东. 63例川崎病合并冠状动脉瘤的中远期随诊[J].中国实用儿科杂志, 2008, 24(1): 37-40.
[3]段超, 杜忠东, 张桂荣,万岁桂,孙雪静. 川崎病冠脉瘤远期血管改变与冠脉粥样硬化关系研究[J]. 中国实用儿科杂志, 2010, 25(10): 759-762.
[4]Stroes ES, Koomans HA, de Bruin TW,Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication[J]. Lancet, 1995, 346(8973): 467-471.
[5]李宏亮, 余叶蓉, 蒲素, 喻红玲, 王椿, 张祥讯. 单纯性肥胖患者氧化应激与内皮依赖性血管舒张功能的关系[J]. 中国糖尿病杂志, 2008, 16(2): 97-100.
[6]Japaness Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Pediatr Int, 2005, 47(6): 711-732.
[7]Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Pediatrics, 2004, 114(6): 1708-1733.
[8]Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J]. Lancet, 1992, 340(8828): 1111-1115.
[9]Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease[J]. Pediatr Cardiol, 2005, 26(6): 782-786.
[10]Kadono T, Sugiyama H, Hoshiai M, Osada M, Tan T, Naitoh A, et al. Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease[J]. Pediatr Cardiol, 2005, 26(4): 385-390.
[11]Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW. Cardiovascular risk factors after Kawasaki disease: a case-control study[J]. J Pediatr, 2001, 138(3): 400-405.
[12]McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?[J]. J Pediatr, 2007, 151(3): 244-248.
[13]Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease[J]. Eur J Pediatr, 2008, 167(2): 189-196.
[14]Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, et al. Endothelial dysfunction late after Kawasaki disease[J]. Circulation, 1996, 94(9): 2103-2106.
[15]解玉,王秀英.川崎病冠状动脉病变与内皮功能障碍[J]. 中国当代儿科杂志, 2003, 5(1): 177-179.
[16]Belhassen L, Carville C, Pelle G, Monin JL, Teiger E, Duval-Moulin AM, et al. Evaluation of carotid artery and aortic intima-media thickness measurements for exclusion of significant coronary atherosclerosis in patients scheduled for heart valv suegery[J]. J Am Coll Cardiol, 2002, 39(7): 1139-1144.
[17]Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C-reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease[J]. Heart, 2004, 90(11): 1281-1285.